University Lecturer in Finance
Fellow, Cambridge Endowment for Research in Finance (CERF)
Official Fellow of Clare Hall
Dipl. Kfm. (Business Administration) (University of Bayreuth), MPhil in Financial Research, PhD in Finance (University of Cambridge)
Finance: Empirical corporate finance particularly mergers & acquisitions, stock market anomalies and investment management. Accounting: Capital markets based accounting research, international accounting particularly fair value accounting, valuation.
Subject group: Finance & Accounting
Amir previously worked for Lehman Brothers, London, in its Fixed Income Structured Solutions Group. He sits on the Board of Directors of the European Financial Management Association and is member of the supervisory board of New Medical Enzymes AG. Amir has been a visiting scholar at Columbia Business School, NYU Stern, and the University of Bologna. He is a member of the Cambridge Corporate Governance Network (CCGN).
Amel-Zadeh, A. and Zhang, Y. (2015) "The economic consequences of financial restatements: evidence from the market for corporate control." The Accounting Review, 90(1): 1-29 (DOI: 10.2308/accr-50869)
Amel-Zadeh, A. and Meeks, G. (2013) "Bank failure, mark-to-market, and the financial crisis." Abacus, 49(3): 308-339 (DOI: 10.1111/abac.12011) (Winner of the Abacus Best Manuscript Award 2013)
Amel-Zadeh, A. and Schreiner, A. (2012) "Die Grössenanomalie am deutschen Aktienmarkt: Rückkehr einer profitablen Arbitragestrategie [in German]." In: Frick, R., Gantenbein, P. and Reichling, P. (eds.) Asset management. Bern: Haupt Verlag, pp.199-218
Amel-Zadeh, A. (2011) "The return of the size anomaly: evidence from the German stock market." European Financial Management Journal, 17(1): 145-182
Dissanaike, G. and Amel-Zadeh, A. (2007) "Venture capitalists, business angels, and performance of entrepreneurial IPOs in the UK and France: a discussion." Journal of Business Finance and Accounting, 34(3/4): 529-540